First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued Long-term Investment Intensity
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued long-term investment intensity. First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) has a Long-term Investment Intensity of 8.0% as of December 2024. Long-term investments of $35.47 Million represent 8.0% of total assets of $441.89 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read TRAXV total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (2023–2024)
Long-term investment intensity of First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued from 2023 to 2024. This chart shows how First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued's Long-term Investment Intensity has evolved across 2 annual periods from 2023 to 2024. As of December 2024, the intensity stands at 8.0%, reflecting long-term investments of $35.47 Million against total assets of $441.89 Million USD.
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued Long-term Investment Intensity by Year (2023–2024)
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued long-term investment intensity by year from 2023 to 2024. The table below presents the year-by-year Long-term Investment Intensity for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued from 2023 to 2024, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see First Tracks Biotherapeutics, Inc. Ordin balance sheet assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 8.0% | $35.47 Million | $441.89 Million | ▲ +1.9 pp |
| 2023 | 6.1% | $27.03 Million | $444.11 Million | — |